Companies / DNA X, Inc.

DNA X, Inc.

Nasdaq: SONMCIK 1178697SAN DIEGO, CAsonimtech.com

Financials · FY2024

Revenue$58.30M
Net income$-20.66M
Total debt$1.07M
Cash$1.20M
Diluted EPS$-28.58
Shares outstanding1.5M

Ownership

1.5M shares outstanding · as of May 14, 2026
6.1%Insiders
Ownership
Insiders6.10%90,790
10%+ / strategic9.96%148,290
Institutions6.68%99,348
Public float77.26%1,149,840

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Mulica Michael CCEOActing CEO · Director
3.63%54,071
Crolius ClaytonChief Financial Officer
2.47%36,719

Institutional holders 10

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 9, 2026Mulica Michael C
CEO
GrantCommon Stock$0+50K
+1228.20%
54,071
3.63% of shares
low
Feb 9, 2026Crolius Clayton
Executive
GrantCommon Stock$0+35K
+2036.07%
36,719
2.47% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lytton Laurence WPassive13G/A148,290
1 Main Capital Management, LLCPassive13G/A
Streeterville Capital LLCPassive13G/A0
Lytton Laurence WPassive13G/A120,357

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SONMCommon StockEquity83548F408BBG000D5J0L9
SONM83548F309